In a filing, KKR & Co. Inc revealed its 10% Owner KKR Genetic Disorder L.P. unloaded Company’s shares for reported $205.2 million on May 12 ’25. In the deal valued at $34.20 per share,6,000,000 shares were sold. As a result of this transaction, KKR Genetic Disorder L.P. now holds 13,260,971 shares worth roughly $1.67 billion.
Then, SCULLY ROBERT W bought 13,250 shares, generating $1,503,733 in total proceeds. Upon buying the shares at $113.49, the Director now owns 13,250 shares.
Before that, KKR Group Partnership L.P. sold 2,948,723 shares. KKR & Co. Inc shares valued at $29,221,845 were divested by the 10% Owner at a price of $9.91 per share. As a result of the transaction, KKR Group Partnership L.P. now holds 0 shares, worth roughly $0.0.
Morgan Stanley upgraded its KKR & Co. Inc [KKR] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including HSBC Securities’s analysts, who increased its forecast for the stock in mid April from “a Hold” to “a Buy”. Wells Fargo also remained covering KKR and has increased its forecast on March 20, 2025 with a “an Overweight” recommendation from previously “an Equal weight” rating. HSBC Securities revised its rating on January 30, 2025. It rated KKR as “a Hold” which previously was an “a Buy”.
Price Performance Review of KKR
On Friday, KKR & Co. Inc [NYSE:KKR] saw its stock jump 0.21% to $125.90. Over the last five days, the stock has gained 6.62%. KKR & Co. Inc shares have fallen nearly -14.88% since the year began. Nevertheless, the stocks have risen 22.90% over the past one year. While a 52-week high of $170.40 was reached on 01/31/25, a 52-week low of $86.15 was recorded on 04/07/25. SMA at 50 days reached $112.75, while 200 days put it at $132.64.
Levels Of Support And Resistance For KKR Stock
The 24-hour chart illustrates a support level at 124.79, which if violated will result in even more drops to 123.67. On the upside, there is a resistance level at 126.84. A further resistance level may holdings at 127.77. The Relative Strength Index (RSI) on the 14-day chart is 62.61, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.27, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 18.87%. Stochastics %K at 85.73% indicates the stock is a selling.
The most recent change occurred on September 18, 2024 when HSBC Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $148 price target.
